# Vir Biotechnology, Inc.: Form 8-K, filed Jan 8, 2025

- Company: [Vir Biotechnology, Inc.](/companies/vir.md) (CIK 1706431)
- Form: 8-K
- Filed: 2025-01-08
- Accepted by EDGAR: Jan 8, 2025, 07:50 ET
- Period: 2025-01-08
- Accession: 0001193125-25-003214
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1706431/000119312525003214/d887412d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1706431/000119312525003214/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1706431/000119312525003214/d887412d8k.htm

Filed Jan 8, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-003214. Last ingested by Listed: Nov 13, 2026, 16:04 ET. No prices; not investment advice.
